Healthcare / Healthcare Providers & ServicesUpdated 2026-05-10 22:07 UTC

LON/0NQH stock hub

LON/0NQH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0NQHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

705.4M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0NQH

In the news

Latest news · LON/0NQH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.1

P25 12.9P50 16.9P75 23.5

Trailing P/E20.2

P25 15.9P50 22.9P75 35.8

ROE3.1

P25 -54.2P50 2.1P75 13.7

ROIC3.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0NQH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

190

Groups with data

Currency

EUR

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	UK
Employees	14,144
Employees Change	4,974%
Employees Change Percent	35.36
Enterprise value	EUR 594M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Healthcare Providers & Services
Isin	DE0007042301
Last refreshed	2026-05-10
Market cap	EUR 705.4M
Price	EUR 12.15
Price currency	EUR
Rev Per Employee	123,662.41x
Sector	Healthcare
Sic	8060
Symbol	lon/0NQH
Website	https://www.rhoen-klinikum-ag.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.96%
EV Earnings	16.98x
EV/EBIT	13.25x
EV/EBITDA	6.18x
EV/Sales	0.34x
Forward P/E	19.13x
P/B ratio	0.59x
P/E ratio	20.17x
P/S ratio	0.4x
PE Ratio10 Y	98.01x
PE Ratio3 Y	21.38x
PE Ratio5 Y	30.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.59%
EBITDA Margin	5.38%
Gross margin	10.43%
Gross Profit	EUR 182.4M
Gross Profit Growth	0.06%
Gross Profit Growth Q	14.57%
Gross Profit Growth3 Y	-4.83%
Gross Profit Growth5 Y	2.22%
Net Income	EUR 35M
Net Income Growth	0.92%
Net Income Growth Q	78.25%
Net Income Growth3 Y	9.63%
Net Income Growth5 Y	41.69%
Pretax Margin	2.6%
Profit Margin	2%
Profit Per Employee	EUR 2,473
ROA	1.74
Roa5y	1.35
ROCE	3.49
ROE	3.12
Roe5y	2.81
ROIC	3.57
Roic5y	2.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.87%
Cagr15y	-0.39%
Cagr1y	-16.12%
Cagr3y	-1.58%
Cagr5y	-4.92%
Div CAGR10	-18.18%
Div CAGR3	-13.2%
Div CAGR5	-8.14%
EPS Growth	-0.84
EPS Growth Q	72.73
EPS Growth3 Y	9.53
EPS Growth5 Y	41.61
Revenue Growth	5.87x
Revenue Growth Q	6.75x
Revenue Growth3 Y	5.82x
Revenue Growth5 Y	5.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.08
Assets	EUR 1.6B
Cash	EUR 140.1M
Current Assets	EUR 791.6M
Current Liabilities	EUR 307.6M
Equity	EUR 1.2B
Interest Coverage	16.86
Liabilities	EUR 415.7M
Long Term Assets	EUR 816M
Long Term Liabilities	EUR 108.1M
Net Cash	EUR 140.1M
Net Cash By Market Cap	EUR 19.86
Net Cash Growth	42.34%
Net Debt EBITDA	EUR -1.49
Net Debt Equity	EUR -0.12
Tangible Book Value	EUR 1B
Tangible Book Value Per Share	EUR 15.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.57
Inventory Turnover	46.69
Net Working Capital	EUR 348.5M
Quick ratio	1.19
Working Capital	EUR 488.6M
Working Capital Turnover	EUR 3.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.77%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	EUR 0.08
Dividend Years	1
Dividend Yield	0.66%
Ex Div Date	2025-06-04
Last Dividend	EUR 0.08

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-50.9%
1Y total return	-16.11%
200-day SMA	12.33
3Y total return	-4.66%
50-day SMA	12.6
50-day SMA vs 200-day SMA	50over200
5Y total return	-22.29%
All Time High	31.84
All Time High Change	-61.84%
All Time High Date	2018-02-01
All Time Low	9.52
All Time Low Change	27.59%
All Time Low Date	2024-02-13
ATR	0.16
Ch YTD	-3.95
High52	14.04
High52 Date	2025-05-12
High52ch	-13.44%
Low52	11.4
Low52 Date	2025-08-14
Low52ch	6.58%
Ma50ch	-3.59%
Price vs 200-day SMA	-1.48%
RSI	41.67
RSI Monthly	46.33
RSI Weekly	40.68
Sharpe ratio	-0.83x
Sortino ratio	-0.87
Total Return	-1.11%
Tr YTD	-3.95
Tr15y	-5.69%
Tr1m	-1.22%
Tr1w	-3.19%
Tr3m	-6.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 45.2M
Operating Income Growth	14.61
Operating Income Growth Q	92.98
Operating Income Growth3 Y	10.2
Operating Income Growth5 Y	56.81
Operating margin	2.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,652,240%
Shares Institutions	0.53%
Shares Qo Q	-0.32%
Shares Yo Y	1.77%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	56.6x
Bv Per Share	17.4
Ch10y	-54.8
Ch15y	-21.46
Ch1m	-1.22
Ch1w	-3.19
Ch1y	-16.78
Ch3m	-6.9
Ch3y	-6.54
Ch5y	-23.82
Ch6m	2.1
Change	-5.08%
Close	12.8
Depreciation Amortization	48,463,400.3
Earnings Date	2026-05-07
EBIT	EUR 45.2M
EBITDA	EUR 94.1M
EPS	EUR 0.52
F Score	4
Fiscal Year End	December
Founded	1,973
Graham Number	16.68068
Graham Upside	37.29
Income Tax	EUR 8.7M
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	EUR 15.06
Lynch Upside	23.95
Ma150	12.51
Ma150ch	-2.84%
Ma20	12.41
Ma20ch	-2.12%
Next Earnings Date	2026-08-06
Payment Date	2025-06-06
Ppne	639,976,393.5
Price Date	2026-05-08
Price EBITDA	EUR 7.49
Ptbv Ratio	0.7
Relative Volume	67.34x
Revenue	1,749,081,163x
Tax By Revenue	0.5x
Tax Rate	19.12%
Tr6m	2.1%

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0NQH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$0.08 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-8.1%

0 consecutive years of growth

Total shareholder yield

-1.1%

Next ex-dividend date: 2025-06-04

Performance

LON/0NQH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0NQH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.8%

Negative means the company is buying back shares.

Technical

LON/0NQH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.7

Neutral momentum band

Price vs 200-day MA

-1.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0NQH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0NQH stock rating?

lon/0NQH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0NQH analysis?

The full report lives at /stocks/lon/0NQH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0NQH?

The latest report frames lon/0NQH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0NQH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.